k@gmail.com'
Tejas Athni



Experience

Content

  • Most Viewed
  • Most Liked

Tab 1

Understanding Patient-Derived Glioblastoma Multiforme Cells’ Proliferation

Glioblastoma multiforme (GBM) is the most common and aggressive type of primary brain tumor. Patients with GBM have a median survival of 15 months. Thus, treating GBM can be achieved by inhibiting the proliferation of the patient-derived cells using leaf extract of B. monnieri.

Tab 2

Understanding Patient-Derived Glioblastoma Multiforme Cells’ Proliferation

Glioblastoma multiforme (GBM) is the most common and aggressive type of primary brain tumor. Patients with GBM have a median survival of 15 months. Thus, treating GBM can be achieved by inhibiting the proliferation of the patient-derived cells using leaf extract of B. monnieri.

ALL ARTICLES

Understanding Patient-Derived Glioblastoma Multiforme Cells’ Proliferation

Glioblastoma multiforme (GBM) is the most common and aggressive type of primary brain tumor. Patients with GBM have a median survival of 15 months. Thus, treating GBM can be achieved by inhibiting the proliferation of the patient-derived cells using leaf extract of B. monnieri.

CONTRIBUTIONS

  • Comments
  • Likes

Tab 3

Tab 4

Tab 5

Reviews
Scroll to top

Send this to a friend